Jounce Therapeutics
company
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data
Net Income
-$50.92M
Assets
$212.55M
EPS (diluted)
$-0.99
Jounce Therapeutics
Summary
Jounce Therapeutics is a business[1].
Key Facts
- Jounce Therapeutics is in the country of United States[2].
- Jounce Therapeutics is in the country of US[3].
- Jounce Therapeutics's instance of is recorded as business[4].
- Jounce Therapeutics's instance of is recorded as public company[5].
- Jounce Therapeutics's headquarters location is recorded as Cambridge[6].
- Jounce Therapeutics's stock exchange is recorded as Nasdaq[7].
- Jounce Therapeutics's industry is recorded as pharmaceutical industry[8].
- January 1, 2013 marks the founding of Jounce Therapeutics[9].
- 2024-07-12 marks the founding of Jounce Therapeutics[10].
- Jounce Therapeutics's official website is recorded as http://jouncetx.com/[11].
- Jounce Therapeutics's legal form is recorded as Delaware corporation[12].
- Jounce Therapeutics's legal form is recorded as 8WM4[13].
Body
Founding
Recorded inception include January 1, 2013[9] and 2024-07-12[10].
Operations
Jounce Therapeutics's headquarters location is recorded as Cambridge[6].
Industry
Jounce Therapeutics's industry is recorded as pharmaceutical industry[8].
Ownership
Jounce Therapeutics's stock exchange is recorded as Nasdaq[7].